Home » Eisai’s Proposed Sedative Gets Not-Approvable Letter From FDA
Eisai’s Proposed Sedative Gets Not-Approvable Letter From FDA
Eisai Co. received a not approvable letter from the Food and Drug Administration for its proposed sedative, but the company said it would work with regulators to gain approval.
WSJ.com
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May